Meet the innovators
Our R&D team are championing innovation in all aspects of pain medicine.
In a world of data and science, it can sometimes be too easy to focus on the numbers and forget about the people. But the real power of our R&D engine comes from our amazing team. Several hundred individuals from around the world come to work each day, dedicated to finding and delivering the next innovative pain therapy for patients.
This spirit of innovation is what drives our company and propels us on our journey towards a World Free of Pain.
Maria Stupar
Global Safety Lead
The efficacy of a product is important, but its safety is everything. Using the power of data, Maria works tirelessly to ensure that we maintain the highest safety standards of our products, from pre-clinical development all the way to commercialisation. Through her efforts, she is ensuring that we continue to stand as a trusted leader in the pain medicine space, for healthcare professionals and the patients we serve.
Chanchal Kumar
Head Bioinformatics, Disease Understanding
With an insatiable desire to turn data into knowledge, Chanchal and his team are leveraging state-of-the-art data analytics and digital technologies to identify the specific cells that lead to chronic pain. In doing so, Chanchal is on the hunt for new precise targets that could represent the future of pain medicine.
Sevil Davidson
Computational Biologist
With the power of artificial intelligence (AI) and machine learning (ML) at her fingertips, Sevil is developing algorithms to predict the properties of different molecules and accelerate the identification of promising therapeutic candidates. By optimising the structures of the molecules that are sent for synthesis in the lab, Sevil ensures that our research efforts are as efficient and sustainable as possible.
Florian Jakob
Head of Drug Discovery Engine
Florian Jakob has always been excited by the idea of taking a tiny molecule and designing it to have a very specific, positive effect for patients. He has grown from an early career researcher into Head of Drug Discovery Engine at Grünenthal. Currently, he advances the leading science of our GRM programme, aiming to create a molecule with anti-inflammatory effects in patients without the side effects of common therapies.
Keith Philips
Head of Genetic Medicine
Keith has science in his genes and today, he contributes to driving our RNA-based research programmes with his international team. A passionate sailor, Keith compares RNA therapeutics to sailing boats – a means of transport that takes cargo to a specific port. And once set up, can set sail again and again with new cargo.
